Molecular characterization of salivary gland malignancy using the Smgb-Tag transgenic mouse model

Laboratory Investigation

Volumn 85, Issue 8, 2005, Pages 947-961

  Mäkitie, Antti A ^a   Dos Reis, Patricia Pintor ^a   Arora, Shilpi ^a   MacMillan, Christina ^b,c   Warner, Giles C ^a   Sukhai, Mahadeo ^a,b   Dardick, Irving ^b   Perez Ordonez, Bayardo ^b,d   Wells, Richard ^a   Brown, Dale ^a   Gilbert, Ralph ^a,e   Freeman, Jeremy ^c,d   Gullane, Patrick ^a,e   Irish, Jonathan ^a,e   Kamel Reid, Suzanne ^a,b,d,e  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenocarcinoma; Carcinogenesis; Gene expression; Microarrays; Salivary gland; Transgenic mouse

Indexed keywords

CD24 ANTIGEN; LIPOCALIN; LIPOCALIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 6; PLEIOTROPHIN; RNA BINDING PROTEIN; SECRETORY PROTEIN; SMGB PROTEIN; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; DYSPLASIA; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENETICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARKER GENE; MOUSE; MYOEPITHELIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA; TRANSGENE; TRANSGENIC MOUSE; VALIDATION PROCESS;

ADENOCARCINOMA; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS;

EID: 27144439487     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700288     Document Type: Article

References (61)

1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002;8:229-240.
2. Dardick I. Salivary Gland Tumor Pathology. Igaku-Shoin Medical Publishers: New York, 1996.
3. Pusztai L, Ayers M, Stec J, et al. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. Clin Cancer Res 2003;9:2406-2415.
4. Watson MA, Gutmann DH, Peterson K, et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 2002;161:665-672.
5. Nielsen TO, West RB, Linn SC, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002;359:1301-1307.
6. Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000;110:374-381.
7. Squire JA, Bayani J, Luk C, et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 2002;24:874-887.
8. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003;9:3058-3064.
9. Warner GC, Reis PP, Jurisica I, et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 2004;110:857-868.
10. Macgregor PF, Squire JA. Application of microarrays to the analysis of gene expression in cancer. Clin Chem 2002;48:1170-1177.
11. Johns III MM, Westra WH, Califano JA, et al. Allelotype of salivary gland tumors. Cancer Res 1996;56:1151-1154.
12. Queimado L, Reis A, Fonseca I, et al. A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas. Oncogene 1998;16:83-88.
13. Cerilli LA, Swartzbaugh JR, Saadut R, et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 1999;30: 1242-1246.
14. Morio T, Morimitsu Y, Hisaoka M, et al. DNA copy number changes in carcinoma in pleomorphic adenoma of the salivary gland: a comparative genomic hybridization study. Pathol Int 2002;52:501-507.
15. Hungermann D, Roeser K, Buerger H, et al. Relative paucity of gross genetic alterations in myoepitheliomas and myoepithelial carcinomas of salivary glands. J Pathol 2002;198:487-494.
16. Stallmach I, Zenklusen P, Komminoth P, et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 2002;440:77-84.
17. Francioso F, Carinci F, Tosi L, et al. Identification of differentially expressed genes in human salivary gland tumors by DNA microarrays. Mol Cancer Ther 2002;1:533-538.
18. Frierson Jr HF, El-Naggar AK, Welsh JB, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002;161:1315-1323.
19. Voz ML, Mathys J, Hensen K, et al. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 2004;23:179-191.
20. Renou JP, Bierie B, Miyoshi K, et al. Identification of genes differentially expressed in mouse mammary epithelium transformed by an activated beta-catenin. Oncogene 2003;22:4594-4610.
21. Bonner AE, Lemon WJ, You M. Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet 2003;40:408-417.
22. Gregory SG, Sekhon M, Schein J, et al. A physical map of the mouse genome. Nature 2002;418:743-750.
23. Gutmann DH, Huang ZY, Hedrick NM, et al. Mouse glioma gene expression profiling identifies novel human glioma-associated genes. Ann Neurol 2002;51:393-405.
24. He LZ, Tribioli C, Rivi R, et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A 1997;94:5302-5307.
25. Sukhai MA, Wu X, Xuan Y, et al. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha. Oncogene 2004;23:665-678.
26. Dardick I, Ho J, Paulus M, et al. Submandibular gland adenocarcinoma of intercalated duct origin in Smgb-Tag mice. Lab Invest 2000;80:1657-1670.
27. Sambrook J, Fritch EF, Maniatis T. In: N Ford, C Nolan, M Ferguson (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: New York, 1989.
28. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
29. Reis PP, Rogatto SR, Kowalski LP, et al. Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002;21:6480-6487.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
31. Soni S, Mathur M, Shukla NK, et al. Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003;107:309-316.
32. Nagayama S, Katagiri T, Tsunoda T, et al. Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 2002;62:5859-5866.
33. Kaplan MD, Baum BJ. The functions of saliva. Dysphagia 1993;8:225-229.
34. Friedman M, Levin B, Grybauskas V, et al. Malignant tumors of the major salivary glands. Otolaryngol Clin North Am 1986;19:625-636.
35. Dardick I, George D, Jeans MT, et al. Ultrastructural morphology and cellular differentiation in acinic cell carcinoma. Oral Surg Oral Med Oral Pathol 1987;63:325-334.
36. Brandwein M, Huvos AG, Dardick I, et al. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:655-664.
37. Delgado R, Klimstra D, Albores-Saavedra J. Low grade salivary duct carcinoma. A distinctive variant with a low-grade histology and a predominant intraductal growth pattern. Cancer 1996;78:958-967.
38. Di Palma S. Epithelial-myoepithelial carcinoma with co-existing multifocal intercalated duct hyperplasia of the parotid gland. Histopathology 1994;25:494-496.
39. Chetty R. Intercalated duct hyperplasia: possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland. Histopathology 2000;37:260-263.
40. Yu GY, Donath K. Adenomatous ductal proliferation of the salivary gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:215-221.
41. Yu GY, Ussmueller J, Donath K. Histogenesis and development of membranous basal cell adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:446-451.
42. Tilli MT, Hudgins SL, Frech MS, et al. Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression. Cancer Res 2003;63:7668-7673.
43. Deuel TF, Zhang N, Yeh HJ, et al. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 2002;397:162-171.
44. Tare RS, Oreffo RO, Sato K, et al. Effects of targeted overexpression of pleiotrophin on postnatal bone development. Biochem Biophys Res Commun 2002;298:324-332.
45. Sugino T, Kusakabe T, Hoshi N, et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am J Pathol 2002;160:1973-1980.
46. Mentlein R, Held-Feindt J. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 2002;83:747-753.
47. Satyamoorthy K, Oka M, Herlyn M. An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin. Pigment Cell Res 2000;13(Suppl 8):87-93.
48. Weber D, Klomp HJ, Czubayko F, et al. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth. Cancer Res 2000;60:5284-5288.
49. Klomp HJ, Zernial O, Flachmann S, et al. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin Cancer Res 2002;8:823-827.
50. Jager R, List B, Knabbe C, et al. Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Br J Cancer 2002;86:858-863.
51. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392.
52. Maruya S, Kim HW, Weber RS, et al. Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. J Mol Diagn 2004;6:180-190.
53. Welsh JB, Zarrinkar PP, Sapinoso LM, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001;98:1176-1181.
54. Kristiansen G, Denkert C, Schluns K, et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 2002;161:1215-1221.
55. Kristiansen G, Schluns K, Yongwei Y, et al. CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003;88:231-236.
56. Schindelmann S, Windisch J, Grundmann R, et al. Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumour Biol 2002;23:139-145.
57. Fogel M, Friederichs J, Zeller Y, et al. CD24 is a marker for human breast carcinoma. Cancer Lett 1999;143:87-94.
58. Chan P, Simon-Chazottes D, Mattei MG, et al. Comparative mapping of lipocalin genes in human and mouse: the four genes for complement C8 gamma chain, prostaglandin-D-synthase, oncogene-24p3, and progestagen-associated endometrial protein map to HSA9 and MMU2. Genomics 1994;23:145-150.
59. Terris B, Blaveri E, Crnogorac-Jurcevic T, et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 2002;160:1745-1754.
60. Monier F, Surla A, Guillot M, et al. Gelatinase isoforms in urine from bladder cancer patients. Clin Chim Acta 2000;299:11-23.
61. Meyer K, Lee JS, Dyck PA, et al. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 2003;24:975-984.